Genenta Science (GNTA)

• Market cap: $33M
• 1 day: -1.4%
• 5 days: -2.08%
• 1 month: -22.1%
• 3 months: -55.38%
• 6 months: -64.57%
• Year to date: 0%
• 1 year: -71.05%
• 5 years: -87.18%
• 10 years: -87.18%
• Sector: Healthcare
• Industry: Biotechnology

About: Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Employees: 13